表紙
市場調查報告書
商品編碼
1036792

乳腺癌和前列腺癌成像技術、市場趨勢和應用(2021 年)

Imaging Breast & Prostate Cancer - Technologies, Market Trends and Applications, 2021

出版日期: | 出版商: TEMATYS - Exploration of Photonics Markets | 英文 80+ Slides | 商品交期: 請詢問到貨日

價格
  • 全貌
  • 簡介
  • 目錄
簡介

乳腺癌和前列腺癌是女性和男性中最常見的兩種浸潤性癌症。

本報告總結了檢測和治療乳腺癌和前列腺癌的現有、新的和不斷發展的成像方法。它還提供有關影響醫療保健市場引入新技術和產品的價值鏈、顯著的未來趨勢和監管方面的信息。

調查目的/目標

  • 徹底分析乳腺癌和前列腺癌的體內成像方式。
  • 對乳腺癌和前列腺癌成像領域的世界概況、流行率、疾病進展、趨勢、法規和現有設施的總結。
  • 詳細瞭解所有成像技術及其市場細分。
  • 提供這些癌症成像的產品範圍、價值鏈、現有和未來的市場趨勢和預測。
  • 分析價值鏈中各個利益相關者和影響者的技術和戰略。

簡介

調查對像:

  • 技術/成像系統 市場數據
  • 體內成像方式
    • 非侵入性(全身/器官)
    • 侵入性(內窺鏡)
  • 篩查診斷手術前手術手術後用法基於技術

現有技術

  • 乳房
  • 前列腺

對醫療的期望

概述:現有技術的特點

特點

  • 軟組織對比
  • 靈敏度
  • 空間分辨率
  • 深度分辨率
  • 功能
  • 電離輻射
  • 數據收集
  • 成本
  • 安全
  • 用戶
  • 兼容性
  • 尺寸
  • 環境安全制約因素

現有技術的現狀

  • 抑製器
  • 期望

市場細分

示例視圖

細分市場

  • 乳房 X 光檢查/X 光 成像

乳腺癌和前列腺癌最常用的成像技術

  • MRI 系統
  • 超聲 系統
  • 光學成像(包括PAI)

主要成像系統廠商概覽

乳房成像

  • 乳房 X 光檢查/X 光
  • 超聲波
  • MRI/核醫學
  • PAI

前列腺成像

  • X 光
  • 超聲波
  • 融合
  • MRI/核醫學
  • PAI
  • 光學

財務/公司收購

融資(2015-2021)+重大併購

主要趨勢

未來成像系統

  • 待批准的產品
  • 批准的產品

總結

市場/預測/預測

示例視圖

目錄

第 1 章介紹

第 2 章乳腺癌/前列腺癌事實

  • 流行率
  • 掃瞄/手術

第三章技術細分

  • 現有技術
  • 乳腺癌/前列腺癌成像技術
  • 乳房成像
  • 前列腺成像
  • 對醫療的期望

第 4 章市場數據和趨勢

  • 市場細分
  • 主要成像系統概述
  • 製造商
  • 市場和預測
  • 融資/收購一家公司

第 5 章顯著的未來研發技術

  • 主要臨床試驗中心/組織
  • 融資/項目
  • 專利情況
  • 主要趨勢

第 6 章監管方面

第 7 章結論

第 8 章關於 TEMATYS

目錄

Breast Prostate cancers are the two most common invasive cancers in women and men, respectively This report summarizes existing, new and evolving imaging approaches for detecting and treating Breast Prostate cancers It also includes information on the value chain, noticeable upcoming trends and regulatory aspects that impact introduction of new technologies and products into the medical market.

STUDY GOALS AND OBJECTIVES

  • To provide a thorough analysis of the in vivo* imaging modalities for BREAST and PROSTATE cancer.
  • To summarize the global overview, prevalence, disease progression, trends, regulations and existing facilities for Imaging BREAST and PROSTATE Cancer.
  • To detail and describe all the imaging technologies and its market segmentation.
  • To provide the product range, value chain, existing and upcoming market trends and forecast for imaging these cancers.
  • To analyse the technologies and strategies of the various actors and influencers in the value chain.

INTRODUCTION

In the report:

  • TECHNOLOGY/IMAGING SYSTEMS for Market Data.
  • In vivo IMAGING MODALITIES including:
    • NON INVASIVE (whole body/organ)
    • INVASIVE (endoscopy)
  • Technologies based on use for SCREENING, DIAGNOSIS, PRE-SURGERY, SURGERY and POST-SURGERY.
  • ex vivo*+ techniques used in intra operative imaging for Breast & Prostate cancer.

*ex vivo imaging techniques used in other stages of disease progression have not been discussed in this report.

EXISTING TECHNOLOGIES

  • BREAST
  • PROSTATE

MEDICAL EXPECTATIONS

OVERVIEW: FEATURES OF EXISTING TECHNOLOGIES

CHARACTERISTICS

  • Soft-tissue contrast
  • Sensitivity
  • Spatial resolution
  • Depth resolution
  • Function
  • Ionizing radiation
  • Data acquisition
  • Cost
  • Safety
  • User-friendliness
  • Size
  • Environmental Safety Constraints

CURRENT SITUATION OF EXISTING TECHNOLOGIES

  • CONSTRAINTS
  • EXPECTATIONS

MARKET SEGMENTATION

SAMPLE VIEW

MARKET BREAKDOWN

  • Mammography/X-ray imaging is almost exclusively used for Breast cancer diagnosis/screening (while only under 5% of prostate cancer imaging is done using X-ray/CT/PET-CT).

Breast & Prostate cancers with
their most used imaging techniques

  • MRI systems are used extensively to extract substantial information from soft tissues And thus, general MRI systems can be adapted and used to image both the Breast as well as the Prostate.
  • Ultrasound systems are also the preferred imaging choice for varied Breast and Prostate cancers, concluding that general Ultrasound systems can be used and adapted with right transducers and probes.
  • Optical imaging (including PAI) is gaining popularity for pre and intra operative imaging procedures, and thus forms a 4th market segment for Breast and Prostate imaging.
  • Hence, when we speak of a 'Breast Cancer/Prostate Cancer Imaging Market', it is only logical to look into these market segments namely: Mammography/X-ray, MRI, Ultrasound and Optical imaging.

*Prostate cancer imaging market might not be a standalone market, but actually co-exists with the bladder/colon/rectum/gynaecological imaging market especially when it comes to ultrasound imaging We could also call it 'Lower-abdominal Imaging market' for simplicity.

OVERVIEW OF KEY IMAGING SYSTEMS' MANUFACTURERS

BREAST IMAGING

  • MAMMOGRAPHY/X-RAY
  • TEMATYS - Exploration of Photonics Markets
  • ULTRASOUND
  • MRI/NUCLEAR MEDICINE
  • PAI

PROSTATE IMAGING

  • X-RAY
  • TEMATYS - Exploration of Photonics Markets
  • ULTRASOUND
  • FUSION
  • MRI/NUCLEAR MEDICINE
  • PAI
  • OPTICAL

FINANCE & TAKEOVERS

FUNDRAISING (2015-2021) + MAIN MERGERS ACQUISITIONS

  • FUNDRAISING >$ 1M
  • MERGERS AND ACQUISITIONS

MAJOR TRENDS

IMMINENT IMAGING SYSTEMS

  • PRODUCTS AWAITING APPROVAL
  • APPROVED PRODUCTS

SUMMARY

MARKET & FORECAST & PERSPECTIVES

SAMPLE VIEW

TABLE OF CONTENTS

1. INTRODUCTION

  • Study Goals and Objectives
  • Information sources and methodology
  • Scope of the report
  • Glossary
  • Definitions
  • List of companies mentioned in the report

2. BREAST PROSTATE CANCER FACTS

  • Prevalence
  • Scanning & Surgeries

3. TECHNOLOGY SEGMENTATION

  • Existing Technologies
  • Imaging Techniques for Breast & Prostate Cancer
  • Breast Imaging
  • Prostate Imaging
  • Medical Expectations

4. MARKET DATA AND TRENDS

  • Market Segmentation
  • Overview of Key Imaging Systems'
  • manufacturers
  • Market and Forecast
  • Finance & Takeovers

5. NOTICEABLE UPCOMING R D TECHNOLOGIES

  • Major centres / organisations for clinical trials
  • Funding / Projects
  • Patents' Landscape
  • Major Trends

6. REGULATORY ASPECTS

7. CONCLUSIONS

8. ABOUT TEMATYS